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Functional Imaging: CT and MRI
Edwin JR van Beek, MD and Eric A Hoffman, PhD
Department of Radiology, Carver College of Medicine, University of Iowa, Iowa City, USA
Abstract
Synopsis—Numerous imaging techniques permit evaluation of regional pulmonary function.
Contrast-enhanced CT methods now allow assessment of vasculature and lung perfusion. Techniques
using spirometric controlled MDCT allow for quantification of presence and distribution of
parenchymal and airway pathology, Xenon gas can be employed to assess regional ventilation of the
lungs and rapid bolus injections of iodinated contrast agent can provide quantitative measure of
regional parenchymal perfusion. Advances in magnetic resonance imaging (MRI) of the lung include
gadolinium-enhanced perfusion imaging and hyperpolarized helium imaging, which can allow
imaging of pulmonary ventilation and .measurement of the size of emphysematous spaces.
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INTRODUCTION
The traditional approach to lung imaging, using so-called high-resolution computed
tomography (HRCT) consisting of 1 mm slices, is increasingly replaced by novel methods.
The introduction of multi-detector row CT (MDCT) has enabled coronal, sagital, and oblique
reformatting at greater spatial resolution than before, while contrast-enhanced CT methods
now allow assessment of vasculature and lung perfusion. Developments do not stop there:
techniques using spirometric controlled MDCT allow for quantification of presence and
distribution of parenchymal and airway pathology, Xenon gas can be employed to assess
regional ventilation of the lungs; and, although many such applications are currently still driven
by research, it is expected that HRCT will become antiquated in the not too distant future as
CT evolves from mere static assessment of morphology into a dynamic and quantifiable tool
for regional assessment of the lung.
Complementary to CT of the lung, magnetic resonance imaging (MRI) of the lung, which
previously was handicapped by field inhomogeneity and the lack of protons in lung tissue, is
developing its own arsenal for lung assessment, both in terms of morphology, pulmonary
circulation, ventilation, and right heart assessment. It is clear that the inherent advantage of
MRI over CT – its lack of ionizing radiation – makes it of primary interest in the field of lung
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diseases which tend to be chronic with acute exacerbations, thus requiring multiple
investigations during the life-span of the patient. Unfortunately, availability of some of the
tools required such as gas polarizers, or MRI techniques such as broadband upgrades, is still
somewhat limited. However, there is a significant drive towards making access easier and in
many centers MRI has already become a main diagnostic tool.
This chapter intends to describe some of the new features involving lung imaging, both from
a CT and a MRI perspective. It is our intention that the reader be familiar with the currently
available techniques as well as those that are expected to reach clinical applications in the near
future.
COMPUTED TOMOGRAPHY
The scanners
Volumetric physiological imaging via x-ray CT had its beginning in the mid 1970’s with the
Dynamic Spatial Reconstructor, the prototype of dynamic volumetric X-ray CT designed and
installed at the Mayo Clinic (1). Much of the work establishing the accuracy and precision of
volumetric lung imaging was performed on the DSR. (1,2). The primary lesson learned from
the DSR was that lungs in particular must be studied dynamically and volumetrically.
Commercial imaging technology lagged significantly behind this early work. The electron
beam CT (EBCT), (3) used parallel X-ray targets to get improved scan speeds up to 50 msec
per slice pair, acquiring eight stacked slices in approximately 224 milliseconds. There have
been rapid advances in speed and resolution with the advent of MDCT (4). Its cone-beam spiral
CT uses a 2D detector array, allowing larger scanning range in shorter time with higher image
resolution (5,6). Acquiring multiple image slices per rotation with rotation speeds as short as
0.3sec allows for a significant reduction in acquisition time. Faster scan times will significantly
impact functional imaging protocols where the rate of perfusion of a contrast agent is measured
over time or gated imaging is needed. We have believed the future of lung assessment resides
with true dynamic low dose volumetric CT scanners that image at least 1/3 of the thorax with
at least a 0.5mm isotropic voxel and achieve a full rotation scan aperture of 150 msec and have
superior contrast resolution for radiopaque gas and injected contrast detection. The system will
be likely coupled with a low Tesla MR scanner which will be used to complement the
information available from the CT image. Patients will be scanned frequently by low tesla MR
and less frequently over time by use of the CT component.
With the introduction of dual source MDCT (7,8)into the clinical arena, scan apertures now
fall below 150 msec, but z axis coverage with single rotation on these scanners remains at
2.4cm. Other single source spiral scanners have advanced to as many as 256 rows of detectors
(9,10) with a z-axis coverage of up to 12cm. By the end of 2007, 128 rows and 4cm z-axis
coverage will be the minimum configuration of the high-end MDCT scanners. With the broader
coverage, retrospective gating methods have emerged for both cardiac as well as pulmonary
imaging whereby, via a very low pitch, images are gathered during the respiratory or cardiac
cycles while recording the physiologic signal together with the projection images.
Prospectively, (11) or retrospectively(10,12–17), the portions of the physiologic cycle of
interest can be selected from within the slow pitch spiral data such that a volumetric image
data set is reconstructed for just that location of the respiratory or cardiac cycle. Multiple
portions of the physiologic cycle can thus be reconstructed to yield a dynamic image sequence
of the organ of interest. (10,12–17) In pulmonary applications, the earliest use of this method
has been in oncology, tracking the maximum trajectory throughout a respiratory cycle for the
purposes of treatment planning. (15,18).
As the scanners become faster with more slices, some have questioned how many slices is
enough. The answer to this question is largely determined by the more advanced functional
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applications such as retrospective gating technologies, ventilation, and/or perfusion imaging.
As discussed below, perfusion and ventilation imaging requires an axial mode of scanning to
dynamically track the first pass of a sharp bolus of contrast agent (approximately 0.5cc/kg over
2–3 seconds injected into the vena cava/right atrial junction). With axial dynamic scanning,
the functional parameter under investigation (ventilation or perfusion in the case of the lung)
is evaluated only as broadly along the z-axis as the coverage of the multiple rows of detectors
will permit (typically 4–12 cm). If it is important to dynamically evaluate the whole lung then
one must have a long z-axis coverage: otherwise the dynamic acquisition will have to be
repeated at multiple levels to gain the z-axis coverage. There must be enough rows of detectors
to maintain structural detail as well as apex-to-base coverage.
With the introduction of dual source CT, there is a growing interest in the use of dual energy
(19–22) as a means of characterizing tissues regionally as well as quantitating local amounts
of a contrast agent. Dual energy imaging permits mathematical separation of the contrast signal
from the background tissue signal on a single scan acquisition, without the. This simultaneous
acquisition avoids the need for acquisition of separate unenhanced and enhanced scans, with
associated of added radiation dose, and alignment challenges due to variations in breath hold,
cardiogenic motion, alterations in chest wall configuration during a breath hold, normal stress
relaxation occurring when the lung is held at a fixed inflation pressure, etc.. In the case of a
perfused blood volume scan used to assess pulmonary emboli, it is possible, through the use
of dual energy whereby one x-ray source is set to 80kV and the other to 140kV, to generate a
virtual contrast-only image as well as a virtual unenhanced image(20). The accuracy of the
Hounsfield units in the virtual unenhanced image remains untested, and thus it is not clear
whether this virtual image data set can be used, for instance, in a density mask analysis seeking
to quantify presence and distribution of emphysema in a smoker being imaged with a contrast
enhanced scan for the detection and characterization of lung nodules.
With the growing use of prolonged infusions of iodinated x-ray contrast agent, to detect
pulmonary emboli, the enhancement has been used as an index of regional pulmonary blood
flow. This has been and should be dubbed as a “perfused blood volume“ scan, (23–25) so as
not to confuse this measure with the quantitative assessment of parenchymal perfusion
discussed below. With dual energy imaging, it may be possible to obtain a volumetric image
of regional ventilation along with regional lung structure by imaging with dual energy spiral
scanning during a single breath of xenon gas . (21,22) This again is an experimental method
yet to be validated against the dynamic xenon CT assessment of regional ventilation discussed
later in this section. The single breath, dual energy xenon method has been successfully
employed in rabbits using a synchrotron source. (26–28)
Quantitative image analysis
Critical to taking full advantage of MDCT (and MRI) is the ability to objectively evaluate the
information content of the images. In the case of the lung, the starting point is reliable detection
of the lungs (29), lobes (30), airways (31–41) , and blood vessels followed by an analysis of
parenchymal attenuation and texture and finally a regional quantification of ventilation and
perfusion parameters. We and others have reviewed these capabilities elsewhere (42,43). With
the advent of MDCT and isotropic voxels, it is now possible to reliably segment the airway
tree to approximately the 5th generation (trachea being generation 0) and many of the 6th and
7th generation branches are captured in the segmentation. Airway wall thickness is commonly
expressed as wall area percent (percent of the area defined by the outer wall of the airway
segment occupied by the airway wall). (44). These measures are being used to assess airway
remodeling in both asthma and COPD. Figure 1 shows a depiction of the airway tree and lobe
segmentation from both a normal non-smoker and a patient with COPD. These images can be
used to not only quantify the airway and parenchyma characteristics but also to provide a
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roadmap linking airway paths to sub-lobar segment. These data were acquired using the VIDA
PW+ workstation (Coralville, Iowa).
Evaluation of the lung at its functional interface
Computer-based methods for objective quantitation of MDCT data sets to compare normal and
diseased lung are increasingly being used in conjunction with 2D data sets. Methods have
ranged from counting the number of voxels below a cut-off (−850, −910, −950HU) (45–56)
to those which make use of measures derived from the histogram including skewness, kurtosis,
etc. (57). High resolution computed tomography (HRCT), enhances the resolving power of the
image (58–62) allowing detection of less severe emphysema. Various computer-assisted
texture based methods have successfully been used for tissue characterization. Traditional
methods of texture analysis can be grouped into statistical, structural, and hybrid methods
(63). Methods for tissue classification typically rely on region gray scale statistical measures
(i.e.: mean, variance, frequency histogram) or textural measures (autocorrelation, co-
occurrence matrices, run-length matrices, etc.) (46,47,55,57,64–74). Lung tissue can be
objectively evaluated using the attenuation of lung tissue, either as mean lung attenuation, or
by measuring the attenuation of lung falling below a set value (the density mask) (46,47,55,
57,73). It has been demonstrated that lung tissue mean attenuation can be an index of
emphysema (46,47,55). However, a later study showed significant lung attenuation variation
in normal individuals that could be misleading (73). To use attenuation distribution as a
quantitative measure, much greater care needs to be taken to assure accurate scanner calibration
in the air-water Hounsfield range and lung volumes at which scanning occurs need to be
standardized. (75–79) Furthermore, one must consider that in a longitudinal pharmaceutical
study lung attenuation is affected oppositely by changes in emphysema status and inflammation
burden. A useful index of peripheral inflammation and airway disease has been a measure of
air trapping. Quantitative tools to access air trapping have been shown to be quite sensitive.
(80,81) A density masking approach alone is not sufficient to distinguish normal from diseased
lung and Uppaluri et al. have introduced what has been dubbed the Adaptive Multiple Feature
Method (AMFM).(82–84) This technique has utilized up to 26 different mathematical
formulations to describe the gray scale heterogeneity of parenchymal regions within CT slices
and then employed a Bayesian classifier to identify the best, small number of mathematical
formulations (“features”) which distinguish one texture (pathologic state) from another‥ More
recently, Xu et al. (85,86) have shown that using volumetric images with isotropic voxels for
3D texture assessment provides significant improvements in the assessment of regional
parenchymal pathology. In one test, Xu et al used the AMFM method, with appropriate training
sets to accurately differentiate the CT scans of normal smokers from those of normal non-
smokers. The use of the texture analysis method is only as good as the training sets developed,
and if it is desirable to use the method for detection of parenchymal pathology undetectable
by the human observer, training paradigms such as the one used by Xu must be established.
Even when the training sets come from CT findings identified by human observers, the
computer-based AMFM can be shown to be more consistent than human observers in its
assessment of lung regions. Quantitation of lung images has become critical as pharmaceutical
and device manufacturers seek to reduce the development time and seek to use imaging as a
tool for the detection of regional lung changes (either a desired effect or an unwanted side
effect) not reflected in the traditional pulmonary function tests which provide a global measure
of the pulmonary physiology, but are relatively insensitive to regional changes. Figure 2
demonstrates a whole lung classification in which the AMFM simultaneously identified areas
of emphysema (red), honeycomb pink), normal (blue), and ground glass (yellow). These data
are from the work of Xu et al (204).
Functional imaging—Numerous imaging-based methods have been developed to assess
ventilation, perfusion, or their functional outcome - gas exchange. Below we will show
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examples of the use of MDCT imaging technology to probe normal and abnormal
cardiopulmonary structure and function. We argue that MDCT technology offers a unique and
comprehensive approach to evaluating the structural and functional complexity of the
respiratory and cardiopulmonary systems.
Ventilation assessed by CT: The measurement of lung ventilation, lung volume, and tidal
volume has traditionally been made for the entire lung, despite the fact that lung function in
both health and disease is inhomogeneous. Attempts have been made to quantify regional
ventilation both directly and indirectly with a variety of invasive techniques or radioisotope
imaging (87–96), but these methods have been limited by invasiveness, poor spatial and
temporal resolution, qualitative nature, and/or complexity. Xenon-enhanced MDCT (Xe-
MDCT) is a method for the non-invasive measurement of regional pulmonary ventilation,
determined from the wash-in and/or wash-out rates of the radiodense, non-radioactive gas
xenon as measured in serially acquired, axial MDCT scans. Little work had been done since
the original description of this technique nearly twenty five years ago (97–100), although the
FDA approval of Xe-MDCT for measurement of cerebral blood flow has met with moderate
clinical acceptance (101). Recently, however, the application of Xe-MDCT for measurement
of regional pulmonary ventilation has been updated, validated, and refined including extension
of the technique to estimate regional perfusion and V/Q (28,102–111) In Figure 3, we
demonstrate a typical Xenon wash-in wash-out attenuation curve in a sheep, along with a color
coded image of regional ventilation. Scanning was accomplished through gated imaging (end-
expiration) as a fixed concentration of Xenon gas was inspired during the wash-in phase and
then room air was inspired during wash-out. A mono-exponential curve is fitted to the wash-
in or wash-out phase, providing a time constant as a measure of ventilation. Because the
dynamic Xe-MDCT method requires the gated acquisition of axial CT images, timed so that
the images are gathered at the same point in a series of standardized tidal breaths, the method
has been most effectively applied to research animals breathing via respirators. The transfer
of this methodology to humans has required the development of sophisticated feedback devices
which monitor respiration via flow meters and displays which provide the subject with
information related to targeted rate and depth of breathing information. Because of the
complexity of such a system, there is considerable interest in the application of a single breath
method utilizing dual energy CT. With the introduction of dual source CT, it is possible to
image a subject during a breath hold following the inhalation of a single breath of a mixture
of xenon and oxygen. With the kV of the two x-ray sources set to 80 and 140kV, it is possible
to use material decomposition methods (19) to separate the xenon signal from the inherent x-
ray attenuation of the lung. (21,22) Saba et al (21) have demonstrated the feasibility of such
an approach, using 80 and 140 kV, during a single breath hold in a sheep. The images are
presented in figure 4 showing the color coded xenon distribution superimposed upon the CT
sections. In this sheep, a region of ventilation deficit in an area presenting with very subtle
ground glass is demonstrated.
With the ability to retrospectively reconstruct 4D image data sets to represent a complete
breathing cycle it becomes possible to assess regional ventilation through the use of image
matching algorithms (12–18,112). Such image matching provides not only regional volume
changes but also regional images of tissue strain, providing potential insights into local tissue
properties such as early fibrosis, etc. The utility of such measures is only just now being
investigated.
Perfusion assessed by CT—Dynamic imaging methods have been used to estimate
arterial, venous, and capillary transit times and capillary flow distributions (113–120). These
methods involve two types of image data collection regimes. Inlet-outlet detection is typically
used for evaluating conducting vessels and whole organ analysis. The other data collection
regime, referred to as residue detection, is typically used, alone or in conjunction with inlet
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detection, for analysis of microvascular regions wherein the individual vessels are below the
resolution of the imaging system. Various approaches for determining blood flow and/or mean
transit time have been described (114,117–127). There have been a growing number of studies,
demonstrating the use of MDCT with infusion of iodinated contrast agent to assess the presence
of pulmonary emboli via visualization of flow voids in peripheral lung segments, and the
improved ability to detect pulmonary emboli, aortic dissection and coronary atherosclerosis
have resulted in the “triple ruleout“ method for use in patients with chest pain (128). One must
take care not to confuse this method to assess “flowing blood volume” with an assessment of
true perfusion parameters. To assess regional parenchymal perfusion via dynamic axial MDCT,
(129,130)we place a catheter in the right ventricular outflow tract in animals and in the superior
vena cava in humans. A sharp (0.5 cc per kg over 2 seconds) bolus of iodinated contrast agent
is delivered during ECG gated axial scanning. Scanning commences 1–2 heart beats prior to
contrast injection with lungs held at functional residual capacity (FRC). By sampling the
reconstructed time-attenuation curves within the region of a pulmonary artery and the lung
parenchyma as shown in figure 5, we are able to calculate regional mean transit times, blood
flow normalized to air or tissue content (131), and we are able to deconvolve the the signals
such that we can estimate the timing of flow within the microvascular bed (129). In figure 5
we show a color coded image of a non-smoker and a smoker with normal pulmonary function
tests but early CT findings of emphysema. Here, color coding provides a regional depiction of
mean transit time. Using this approach, Alford et al(132) have demonstrated that heterogeneity
of mean transit times is significantly increased in lung regions of smokers who have normal
pulmonary function tests but who have very early CT evidence of emphysema. Through a series
of publications recently (133–135)) Hoffman and colleagues have used functional CT imaging
to demonstrate that hypoxic pulmonary vasoconstriction is normally blocked when hypoxic
conditions are accompanied by inflammation. These observations have lead to the hypothesis
that the failure of inherent mechanisms to block the normal hypoxic pulmonary vasoconstrictor
(HPV) response of the pulmonary vasculature in the presence of inflammatory processes may
lead to a failure of the normal response mechanisms serving to limit the inflammatory response
and thus lead to the emphysema process. Figure 6 provides a demonstration of both an intact
hypoxic pulmonary vasoconstrictor response as well as an inflammation-based blocking of the
hypoxic pulmonary vasoconstrictor response in the same sheep. This animal had an
endobronchial valve placed which allowed air out but not into a regional segment of the lung.
At the same time, the animal arrived in the lab with regional pneumonia. The images
demonstrate that in the region of the valve, there is a shunting of blood flow away from the
hypoxic lung region while in the dependent regions of pneumonia, blood flow shunted away
from the valve region is preferentially distributed to the region of inflammation because it
presumably represents the path of least resistance. We show these images to demonstrate the
power of advanced MDCT imaging to provide a link between structure and function.
MAGNETIC RESONANCE IMAGING
MRI has several advantages over CT, including speed of imaging, lack of ionizing radiation,
ability to identify tissue characteristics and potential to obtain information on different nuclei
allowing for novel approaches to lung function and micro-structure assessment.
Technical requirements
Most modern MR systems will be capable of obtaining excellent quality proton images of the
chest. This will lead to relatively black lungs and excellent delineation of the chest wall,
mediastinum and diaphragm. Parallel imaging sequences assist in obtaining images faster,
within a single breath-hold, thus allowing for rapid image acquisition without the issue of
motion artifact (136–138) A host of sequences are available, ranging from those focused on
the diaphragm and mediastinum to those aimed at obtaining signal from the actual lungs
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themselves. Using intravenous Gadolinium-based contrast agents, it is possible to delineate
the pulmonary vascular tree as well as the right heart. Within the chest, MR images are almost
always obtained during a single breath-hold, although dynamic imaging during a respiratory
cycle is feasible (for instance to demonstrate diaphragm excursions). Ultrafast imaging is also
capable of obtaining dynamic contrast images, leading to interpretation of pulmonary
perfusion.
Proton imaging
As with any MRI technique, proton imaging uses the large magnetic field and the free moving
protons to derive signal from changes in proton orientation due to radiofrequency pulses. The
lungs are different from the rest of the body, as there is a relative low number of protons and
most of the lung parenchyma consists of air. Although this is a problem, it can be used to
advantage as pathological processes tend to increase the number of protons (hemorrhage,
edema, inflammation, or tumor) or alternatively lead to relative voids of proton density (as
with calcification or fibrosis).
The application of differently weighted sequences will lead to increase or decrease in proton
signal. For instance, water will lead to increased signal on T2 weighted and decreased signal
on T1 weighted sequences, whereas fat will have increased signal on both sequences.
Moreover, it is possible to produce fat saturation pulses, resulting in complete depression of
signal from fat.
In order to achieve faster imaging times, several techniques may be used. The oldest of these
uses half-Fourier techniques, which only reconstruct slightly more than half the data space and
extrapolate the missing data. This led to the single breath-hold sequences, which tend to be
slightly T2 weighted, and that are also employed in a variety of other body imaging
applications, such as MRCP. The newer MRI systems all have the ability to perform parallel
imaging techniques, which is somewhat similar to multidetector row CT in that multiple slices
are excited and read out simultaneously, thus increasing temporal resolution by a factor of 2–
8.(136–138)
Although MRI has never really played a major role in routine chest imaging, several
pathological processes can be evaluated using proton imaging, including pleural effusions,
pneumonia, lung tumors (particularly useful in Pancoast tumors and for determination of tumor
invasion in mesothelioma) and the assessment of the mediastinum (Figure 7). (139–141).The
technique is complementary to CT, although tissue plane definition and characterization is
better using MRI.
Assessment of respiratory dynamics has become feasible with the advent of ultrafast proton
imaging capabilities. This has resulted in novel approaches for assessment of diaphragm and
chest wall motion assessment and breathing mechanics.(142,143).
Gadolinium-enhanced imaging
The use of Gadolinium contrast has enabled a rapid expansion of chest MR imaging, as it
became feasible to assess enhancement of pathological processes as well as visualization of
the pulmonary vascular tree (both as static component and dynamics of perfusion) and the other
large arteries. (144). This allowed MRI to become competitive with more traditional CT
techniques in several aspects of chest imaging, particularly imaging of the large vessels,
including congenital anomalies such as patent ductus arteriosus (Figure 8) and the assessment
of pulmonary hypertension (Figure 9). (145,146) Although CT has maintained a primary role
in the diagnosis of pulmonary embolism, the application of MRI for subsets of patients like
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pregnant women or those that will require follow-up imaging to assess response to therapy is
now feasible with very high-resolution MR angiographic imaging. (147–149)
In addition to the above described imaging techniques, MRI offers the possibility to assess
perfusion of the lung vascular bed by ultra-fast imaging during the injection of Gadolinium
contrast.(150,151) This enables direct visualization of regional perfusion, with the possibility
of some form of quantification (though this is notoriously difficult in MRI due to signal-noise
properties). Several studies have now demonstrated the feasibility of this technique for
assessment of normal and pathological processes. (152–155) This application is now very close
to general introduction into clinical practice.
Hyperpolarized gas imaging
MR imaging is versatile and has the capability to image other nuclei, including 3-Helium and
129-Xenon, provided the frequency of the system is adapted accordingly (for instance, for
imaging 3-Helium at a field strength of 1.5 Tesla, the radiofrequency amplifier and transmit/
receive radiofrequency coils are tuned to 48 MHz, compared with 64 Mhz for proton imaging).
(156) Researchers discovered the potential of these noble, stable gas isotopes as a side-effect
to nuclear physics experiments, which required hyperpolarization of 3-He to produce neutron
mirrors. Hyperpolarization is a process whereby the atoms are brought to a higher energy level
by introduction of laser light at the appropriate bandwidth. When this is achieved within a low
magnetic field, the normally random population of spins will change to have a relatively higher
population of atoms with spins aligned along the magnetic field. When this gas is introduced
in a MRI environment, the usual RF frequency and response will result in enhanced signal,
and this application successfully obtained the first images in the early-mid 1990s. (157–159)
Among the noble gases, the application of hyperpolarized 3-He has so far been widely used in
clinical research studies, as the gas has better signal-to-noise ratio and remains in the airways
without further interaction with the human body (in contrast to 129-Xe, which is lipid soluble
and has anesthetic properties at higher concentrations). (156) However, improvement in
hyperpolarization systems has meant that 129-Xenon MR imaging is making rapid strides
forward, giving new insight in lung function. (160–162).One of the main features of
hyperpolarized gas imaging is that the signal introduced in the system is so high that imaging
is less dependent on field strength than is the case for proton imaging, and this has advantages
as lower field-strength magnets may result in fewer artifacts. (163–165) A main disadvantage
to this technique is that the contrast is exogenous, and is non-renewable. In order to maximize
the use of the contrast, one must design special pulse sequences, to minimize loss of polarization
by RF pulses and the paramagnetic effects of oxygen (more about this below). Several such
techniques have been developed for hyperpolarized 3-Helium MRI and these have found a
broad range of applications that may be of interest for the future assessment of pathophysiology
as well as normal lung function and structure.
All hyperpolarized gas imaging techniques rely on the delivery of a single breath of gas mixture
into the airways, with the hyperpolarization either performed on site or by a central distribution
network. (166) This is usually achieved through the inhalation of the content of a plastic
(Tedlar) bag, followed by a breath-hold lasting up to 16 seconds. Several thousands of
applications have now taken place world-wide, and no significant adverse events have been
observed. (167,168)
Ventilation distribution is built on the notion that any area with signal is a reflection of the
delivery of 3-He gas to this area. It is possible to obtain a 3D volumetric dataset of the lungs
using this technique (169), and several authors have shown the utility of this technique in
normal volunteers, patients with asthma, emphysema (including alpha-1-antitrypsin
deficiency; Figure 10A), cystic fibrosis (Figure 10B) and lung cancer (Figure 10C). (170–
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177) There is homogeneous ventilation distribution in normal volunteers, although small
ventilation defects are frequently seen. (170,178–180) In smoking subjects with normal
pulmonary function tests, ventilation defects are usually already detectable. (181) In patients
with emphysema, ventilation defects tend to be worse than in normal smokers and correlate
with pulmonary function tests. (170,180) In asthmatic subjects, ventilation defects can be
provoked using methacholine, and these are reversible using bronchodilator and correlate with
pulmonary function tests (171,182) but quantification can be slightly more problematic. One
method, using a subtraction of the proton MR mask from the hyperpolarized 3-He images has
shown a very good repeatability with robust measurements and effectively yields “ventilated
lung” as a percentage of overall chest cavity volume in a group of normal and smoking subjects.
(183)
A limited study has been performed in patients with lung cancer, suggesting that it may be
feasible to use hyperpolarized 3-He MRI as a tool for the planning of radiation fields, offering
the possibility of higher tumor dose and sparing of relatively healthy lung and thereby the
reduction of radiation pneumonitis. (177) Finally, limited studies in lung transplant recipients
showed that 3-He MRI was capable of detecting abnormal ventilation (184) and more sensitive
than HRCT or spirometry for the detection of bronchiolitis obliterans and ventilation
abnormalities. (185,186)
Diffusion imaging is feasible, making use of the very high diffusivity of 3-He. When using
several RF pulses separated by a pre-determined time interval, the MR system is capable of
obtaining information on the distance traveled by the atoms. In a free open environment, this
is significantly further compared to a restricted environment that exists within the lung and
airways. Thus, the lung structure actually reduces the effective diffusion distance due to
Brownian motion of 3-He atoms, leading to what is known as apparent diffusion coefficient
(ADC) measurements, which are a direct representation of small airways size and correlated
closely with histology. (187) Discussion has taken place whether these measurements represent
terminal bronchioles, and different techniques are under development to assess longer or
shorter measurement times, thus allowing for assessment of collateral ventilation (longer time
scales) or true alveolar measurements (shorter time scales). (188,189)
ADC works by application of gradient echo pulse sequences at two different intervals, resulting
in changes of polarization loss between more or less confined atoms. The ratio of these
polarization changes allow the spatial mapping of ADC, with higher values allocated to larger
air spaces (such as trachea and large bronchi). (190) ADC is homogeneously distributed in
normal subjects, and becomes progressively more heterogeneous with normal smokers to
emphysema (191–194). ADC has been shown to increase under the influence of aging (195,
196), emphysema (194,197,198) and due to gravity dependent compression of the lung (199);
Figure 11). A significant issue is the fact that ADC measurements can only take place in areas
where 3-He signal is present. In disease states with airway obstruction, such as seen in mucus
plugging, this will affect the overall results.
Dynamic ventilation imaging enables the visualization of the 3-He signal as it flows into the
main airways down to the peripheral airspaces, and makes use of a combination of ultra-fast
imaging sequences and image reconstruction techniques that effectively interpolate the
changes that occur during the imaging process, resulting in frame rate in the order of 5–10 ms.
(200,201) . Ventilation can be quantified by obtaining curves of signal change during the
imaging time, and it appears that the resulting curves closely correlate with (overall) lung
function tests, as demonstrated in Figure 12 in a young patient with cystic fibrosis. (202,203)
In addition, by prolonging the duration of the imaging process or by starting the MR data
acquisition later in the respiratory cycle, it is possible to assess for regional airtrapping, which
may be relevant in various types of airway outflow obstruction.
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Oxygen sensitive imaging uses the paramagnetic effect of oxygen as a calculable decrease in
the signal of 3-He due to loss of polarization. Thus, in areas where oxygen is absorbed rapidly
(e.g. ventilation-perfusion matching) the signal of 3-He will remain, whereas areas where
oxygen remains in the airways (e.g. ventilation-perfusion mismatch) demonstrate a faster signal
loss. (204–206); It is now feasible to obtain 3D maps of oxygen uptake ratios (or ventilation-
perfusion maps) using a single breath-hold technique. (207) The method is still under
development, but may be able to assist, among many other options, the assessment of
pulmonary thromboembolic disease (in particular chronic disease patients in the pre-operative
assessment of thromboendarterectomy), the planning of surgical or endobronchial
interventions and the pre-operative assessment of patients with borderline respectability of
lung cancer. Several groups have demonstrated the feasibility of combining perfusion and
ventilation studies in animal model settings .(208,209)
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Glossary
Apparent diffusion coefficient, A measure of the peripheral air space size in the lung as assessed
via polarized gas methods
Attenuation, The unit of measure of a CT scan related to regional lung tissue density
Density mask, A measure of the number of voxels in a region of interest (such as the lung field)
which fall below or above a given Hounsfield Unit
Dual energy CT, Use of CT images obtained with the x-ray guns set at two different kilo voltage
settings (such as 80 and 140kV) to allow for the seperation coincident materials such as tissue
and iodine or iodine and bone, etc.
Dual source CT, Use of two x-ray guns and associated detector rows on a single rotating gantry
to allow for more rapid acquisition of projection images used in the image reconstruction
process. This reduces motion blur of rapidly moving structures such as the heart and allows
for the use of dual energy imaging for the separation of coincident materials. (see above)
Dynamic scan, Imaging in an axial mode in rapid succession either through timing or gating
to a physiological signal. The temporal series of images are used to assess physiological events
such as respiration, blood flow, cardiac wall contraction, etc.
Gating, Timing of image acquisition (projection images in the case of CT scanning) such that
the projection images are gathered at a fixed point of a physiological cycle such as a particular
point in the respiratory or cardiac cycles.
Gray scale, A scaled representation of the x-ray attenuation coefficients within the
reconstructed cross sections produced through the process of CT imaging.
Hounsfield units, A scaled representation of the x-ray attenuation coefficient also refered to as
the image "gray scale." Air is −1000, water is 0 and dense bone is +1000.
Multi-detector row CT (MDCT), A CT scanner which utilizes a cone beam x-ray source,
coupled with more than one row of juxtaposed detectors to allow for the more rapid acquistion
of projection data used to reconstruct CT cross sectional images. Currently scanners are
available for clinical use with up to 320 rows of detectors.
Pitch, Table travel divided by the total collimation of the x-ray beam.
Scan aperture, Time required to generate the projections used in the reconstruction of a CT
slice. This may take the form of an effective scan aperture if a short period of time within
multiple physiological cycles are used in the reconstruction process. The period of time within
a single cycle would be considered to be the "scan aperture."
Spiral CT, A method whereby projection images are gathered as the patient is moved through
the scanning plane.
Tesla, A measure of magnetic flux per square meter
Volumetric, the acquisition of a stack of cross sectional images with near isotropic voxels.
Voxel, An image volume element. The two dimensional equivalent is a pixel. The term voxel
recognizes that a cross sectional image has a thickness. A voxel is a three-dimensional point
in space for which there is a reconstructed value (in the case of CT this is the x-ray attenuation
coefficient or Hounsfield unit, in MRI the value can represent many different units of measure).
Z-axis, The axis running perpendicular to the scanned plane, typically head to foot in a
recumbent patient.
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Figure 1.
Images derived from MDCT-based imaging of a normal non-smoker (left) and a smoker with
emphysema (right). These images demonstrate the automatic segmentation of the lungs, lobes
and bronchial tree with automatic bronchial tree labeling. Segmentation and display was via a
Pulmonary Workstation Plus (VIDA Diagnostics: Coralville, Iowa)
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Figure 2.
Whole lung classification using the 3D AMFM. Ellipses in the original image slice (left)
represent emphysema (red) and honeycomb (purple) patterns. The tissue types are color coded
as: Red=emphysema, pink=honeycomb, blue=normal, and yellow=ground glass. (Data are
from the thesis work of Ye Xu, University of Iowa, 2007)
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Figure 3.
Demonstration of the density changes occurring regionally across time as a result of the re-
breathing of a constant concentration of xenon gas. Imaging is in the axial mode and scans are
gated to end expiration. Data shown are from a supine anesthetized pig. In the upper panel,
regions of interest are sampled including parenchymal regions spaced from the dependent to
the non-dependent lung regions, with one region of interest in a right sided bronchus. It can be
seen that the exponential rise from baseline is sharper in the dependent (yellow) region vs a
much shallower exponential rise in the non-dependent region (blue). The sharp and shallow
rise from baseline represent a fast or slow gas turnover rate respectively. Note the gradient in
specific ventilation (lower right) where specific ventilation is the gas turn over rate (time
constant) normalized by the local amount of air in that region of lung.
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Figure 4.
Dual energy color coded images in axial (a) and coronal (b) planes demonstrate the presence
of xenon gas following the inhalation of a single breath of 80% xenon. Imaging was
accomplished in the prone position at 80 and 140kV, allowing subtraction of the xenon signal
while minimally changing the signal from the natural occurring tissue of the body. Note the
region of low or no xenon ventilation (white arrows, upper panel). This region had a ground
glass pattern indicative of regional small airway inflammation. Data from the work of Fuld et
al. [56] and Saba et al. [145]
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Figure 5.
Regional assessment of pulmonary blood flow mean transit times via use of temporally
sequenced axial imaging, gated to the electrocardiogram during a sharp bolus contrast injection
(0.5cc/kg iodinated contrast agent) into the superior vena cava / right atrial junction in a normal
non-smoking (upper left) and a smoker (lower left) with CT showing only findings of early
emphysema. Regions of interest are highlighted in the lower left image showing an ROI placed
in the pulmonary artery (yellow); non-dependent (red) and dependent (purple) parenchymal
regions. Associated time intensity curves are shown, from which mean transit times and
pulmonary blood flow may be calculated, with the parenchymal curves expanded in the lower
right graph. Studies have shown that the regional heterogeneity of pulmonary blood flow mean
transit times are significantly increased in the smokers with CT findings of emphysema. Data
from the work of Alford et al [3]
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Figure 6.
Axial images from a sheep with native pneumonia (dependent lung regions), imaged supine,
anesthetized in the MDCT scanner. Ventilation (middle column) and perfusion (left column)
data sets were obtained before (upper rows) and after (lower rows) the placement of an
endobronchial valve. The white arrow in the lower middle column marks the location of
ventilation defect caused by the endobronchial valve. In this same region on the perfusion
images (see lower right) there is a regional reduction in perfusion indicating regional, intact
hypoxic pulmonary vasoconstriction. The black arrow in the lower right image marks a region
that preferentially receives an increase in blood flow following the shunting of perfusion from
the regional of the endobronchial valve, presumable because regional HPV is blocked in the
presence of inflammation. Reprinted with permission from [74]
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Figure 7.
Patient with sarcoidosis. Coronal proton single shot fast spin echo sequence, demonstrating
black lungs with some interstitial markings and extensive mediastinal and bilateral hilar
lymphadenopathy.
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Figure 8.
Sagittal 3D-Gadolinium-enhanced MR angiogram, demonstrating direct connection between
aorta and pulmonary artery (arrow), consistent with patent ductus arteriosus in a patient with
pulmonary hypertension.
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Figure 9.
Coronal 3D-Gadolinium-enhanced MR angiogram, demonstrating enhancement of an
aneurysm of the right pulmonary artery with a black rim of mural organized thrombus (arrow)
in a patient with pulmonary hypertension.
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Figure 10.
Examples of hyperpolarized 3-Helium MRI and correlation with HRCT. A, B Patient with
alpha-1-antitrypsin deficiency. Notice basal ventilation defects on coronal MRI (a), with
corresponding panlobular emphysema on axial CT (b). C, D Patient with cystic fibrosis. Notice
upper lobe cystic bronchiectasis on axial HRCT (C) with corresponding ventilation defects on
coronal hyperpolarized 3-He MRI (D). E,F Patient with lung cancer. On coronal proton image
a large soft tissue mass is visualized in the right upper lung(E), which corresponds to upper
lobe ventilation defect on hyperpolarized 3-He MRI (F).
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Figure 11.
Apparent diffusion coefficient (ADC) imaging in a normal volunteer in different positions,
demonstrating gravity dependent changes with decreased ADC values in dependent lung
portions (reproduced from Fichele et al. J MRI 2004;20:331–335.)
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Figure 12.
Dynamic 3-He MRI reconstruction of signal change over time during single inspiration
demonstrates the slope of the curve, which may be translated to forced inspiratory volume
during 1 second (reproduced from Koumellis et al. J MRI 200522:420–426.)
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